Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial - Ferreri, AJM; Cwynarski, K; Pulczynski, E (Lancet Haematol, 2016)
et al.